Unknown PHASE4 INTERVENTIONAL 2-arm NCT04286503

The Clinical Study of Carrimycin on Treatment Patients With COVID-19

The Efficacy and Safety of Carrimycin Treatment in Patients With Novel Coronavirus Infectious Disease (COVID-19) : A Multicenter, Randomized, Open-controlled Study

Sponsor: Beijing YouAn Hospital

Conditions Novel Coronavirus Infectious Disease (COVID-19)

Interventions Carrimycin basic treatment lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate

Updated 10 times since 2020 Last updated: Feb 25, 2020 Started: Feb 23, 2020 Primary completion: Feb 28, 2021 Completion: Feb 28, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Novel Coronavirus Infectious Disease (COVID-19), this trial is ongoing. The trial is conducted by Beijing YouAn Hospital and has accumulated 10 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

10 versions recorded

Mar 2026 — Present [monthly]

Unknown PHASE4
Aug 2025 — Mar 2026 [monthly]

Unknown PHASE4
Mar 2025 — Aug 2025 [monthly]

Unknown PHASE4
Sep 2024 — Mar 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown

▶ Show 5 earlier versions

Dec 2022 — Jul 2024 [monthly]

Unknown Status PHASE4
Mar 2022 — Dec 2022 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Oct 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE4
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE4
Mar 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing YouAn Hospital
First Affiliated Hospital of Chongqing Medical University
Huangshi Central Hospital
Institute of Medicine and Biotechnology, Chinese Academy of Medical Sciences
Nanyang Central Hospital
No.2 People's Hospital of Fuyang City
Renmin Hospital of Wuhan University
Shenyang Pharmaceutical University
Shenyang Tonglian Group CO., Ltd
The First Affiliated Hospital of Bengbu Medical University
The Second Affiliated Hospital of Harbin Medical University
The Sixth People's Hospital of Shenyang

Data source: Beijing YouAn Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.